tiprankstipranks
Trending News
More News >
Venus Medtech (Hangzhou), Inc. Class H (HK:2500)
:2500
Hong Kong Market
Advertisement

Venus Medtech (Hangzhou), Inc. Class H (2500) Ratios

Compare
0 Followers

Venus Medtech (Hangzhou), Inc. Class H Ratios

HK:2500's free cash flow for Q4 2024 was ¥0.77. For the 2024 fiscal year, HK:2500's free cash flow was decreased by ¥ and operating cash flow was ¥-2.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.22 2.00 5.02 16.49 8.29
Quick Ratio
1.95 1.86 4.81 16.06 8.14
Cash Ratio
0.82 0.96 3.82 14.17 6.68
Solvency Ratio
-0.58 -0.39 -0.61 -0.67 -0.31
Operating Cash Flow Ratio
0.07 -0.76 -1.48 -2.19 -0.58
Short-Term Operating Cash Flow Coverage
1.36 -1.33 -3.28 -93.25 0.63
Net Current Asset Value
¥ -236.19M¥ 113.70M¥ 817.45M¥ 2.96B¥ 2.90B
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.19 0.15 <0.01 -0.09
Debt-to-Equity Ratio
0.17 0.28 0.22 <0.01 -0.10
Debt-to-Capital Ratio
0.14 0.22 0.18 <0.01 -0.11
Long-Term Debt-to-Capital Ratio
0.11 0.08 0.14 0.00 0.00
Financial Leverage Ratio
1.47 1.51 1.46 1.12 1.13
Debt Service Coverage Ratio
-17.26 -1.04 -3.61 -46.71 0.40
Interest Coverage Ratio
-20.82 -9.41 -24.42 -326.26 -109.89
Debt to Market Cap
0.17 0.32 0.14 <0.01 -0.01
Interest Debt Per Share
0.88 2.03 1.92 0.02 -0.91
Net Debt to EBITDA
-0.12 -0.09 0.98 8.90 17.51
Profitability Margins
Gross Profit Margin
78.11%79.21%77.25%77.99%82.33%
EBIT Margin
-153.78%-136.89%-273.51%-90.33%-66.54%
EBITDA Margin
-130.19%-111.49%-245.87%-77.92%-55.36%
Operating Profit Margin
-73.61%-120.07%-268.11%-149.46%-85.94%
Pretax Profit Margin
-157.32%-149.65%-284.49%-90.79%-67.32%
Net Profit Margin
-151.71%-143.22%-276.05%-89.31%-66.25%
Continuous Operations Profit Margin
-152.36%-148.37%-276.05%-89.31%-66.25%
Net Income Per EBT
96.44%95.70%97.03%98.37%98.40%
EBT Per EBIT
213.71%124.64%106.11%60.75%78.33%
Return on Assets (ROA)
-21.98%-15.94%-21.24%-7.27%-4.23%
Return on Equity (ROE)
-28.94%-24.10%-31.10%-8.17%-4.79%
Return on Capital Employed (ROCE)
-12.00%-16.35%-22.75%-12.68%-6.06%
Return on Invested Capital (ROIC)
-11.40%-14.26%-24.01%-13.44%-6.79%
Return on Tangible Assets
-40.43%-24.79%-32.69%-8.67%-5.10%
Earnings Yield
-43.52%-31.56%-20.35%-3.51%-0.67%
Efficiency Ratios
Receivables Turnover
1.42 1.69 1.34 1.38 1.19
Payables Turnover
3.41 3.02 10.13 10.46 9.21
Inventory Turnover
1.05 0.90 0.89 1.01 0.81
Fixed Asset Turnover
0.90 0.71 0.86 1.59 2.52
Asset Turnover
0.14 0.11 0.08 0.08 0.06
Working Capital Turnover Ratio
0.90 0.35 0.16 0.13 0.10
Cash Conversion Cycle
496.86 498.41 648.52 591.26 714.20
Days of Sales Outstanding
256.69 215.87 272.44 265.15 305.48
Days of Inventory Outstanding
347.20 403.49 412.11 361.02 448.36
Days of Payables Outstanding
107.03 120.95 36.03 34.90 39.63
Operating Cycle
603.89 619.36 684.55 626.16 753.83
Cash Flow Ratios
Operating Cash Flow Per Share
0.05 -1.39 -1.67 -1.04 -0.58
Free Cash Flow Per Share
-0.04 -1.99 -2.07 -1.37 -0.88
CapEx Per Share
0.09 0.60 0.41 0.33 0.30
Free Cash Flow to Operating Cash Flow
-0.75 1.43 1.25 1.32 1.52
Dividend Paid and CapEx Coverage Ratio
0.57 -2.32 -4.08 -3.15 -1.91
Capital Expenditure Coverage Ratio
0.57 -2.32 -4.08 -3.15 -1.91
Operating Cash Flow Coverage Ratio
0.06 -0.74 -0.92 -93.25 0.63
Operating Cash Flow to Sales Ratio
0.05 -1.24 -1.79 -1.10 -0.86
Free Cash Flow Yield
-1.09%-39.15%-16.47%-5.69%-1.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.30 -3.17 -4.91 -28.47 -148.93
Price-to-Sales (P/S) Ratio
3.49 4.54 13.57 25.42 98.66
Price-to-Book (P/B) Ratio
0.74 0.76 1.53 2.33 7.14
Price-to-Free Cash Flow (P/FCF) Ratio
-92.11 -2.55 -6.07 -17.56 -75.43
Price-to-Operating Cash Flow Ratio
69.13 -3.66 -7.56 -23.14 -114.91
Price-to-Earnings Growth (PEG) Ratio
0.06 0.09 -0.02 -0.32 2.36
Price-to-Fair Value
0.74 0.76 1.53 2.33 7.14
Enterprise Value Multiple
-2.79 -4.16 -4.54 -23.73 -160.70
Enterprise Value
1.71B 2.28B 4.53B 7.69B 24.56B
EV to EBITDA
-2.79 -4.16 -4.54 -23.73 -160.70
EV to Sales
3.64 4.64 11.15 18.49 88.97
EV to Free Cash Flow
-96.10 -2.61 -4.99 -12.77 -68.02
EV to Operating Cash Flow
72.13 -3.74 -6.22 -16.83 -103.63
Tangible Book Value Per Share
1.66 3.07 4.07 8.68 7.63
Shareholders’ Equity Per Share
5.05 6.67 8.24 10.36 9.32
Tax and Other Ratios
Effective Tax Rate
0.03 <0.01 0.03 0.02 0.02
Revenue Per Share
1.08 1.12 0.93 0.95 0.67
Net Income Per Share
-1.63 -1.61 -2.56 -0.85 -0.45
Tax Burden
0.96 0.96 0.97 0.98 0.98
Interest Burden
1.02 1.09 1.04 1.01 1.01
Research & Development to Revenue
0.72 1.07 1.30 0.62 0.61
SG&A to Revenue
0.31 0.31 0.47 0.31 0.38
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.03
Income Quality
-0.03 0.87 0.63 1.21 1.28
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis